chr1-229432333-G-T
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001100.4(ACTA1):c.553C>A(p.Arg185Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R185C) has been classified as Pathogenic.
Frequency
Consequence
NM_001100.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACTA1 | NM_001100.4 | c.553C>A | p.Arg185Ser | missense_variant | 4/7 | ENST00000366684.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACTA1 | ENST00000366684.7 | c.553C>A | p.Arg185Ser | missense_variant | 4/7 | 1 | NM_001100.4 | P1 | |
ACTA1 | ENST00000366683.4 | c.553C>A | p.Arg185Ser | missense_variant | 4/7 | 5 | |||
ACTA1 | ENST00000684723.1 | c.418C>A | p.Arg140Ser | missense_variant | 3/6 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Actin accumulation myopathy Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 24, 2021 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg185 amino acid residue in ACTA1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10508519, 15226407, 24313005). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACTA1 protein function. ClinVar contains an entry for this variant (Variation ID: 420099). This variant is also known as Arg183Ser. This missense change has been observed in individual(s) with autosomal dominant nemaline myopathy (PMID: 12921789). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 185 of the ACTA1 protein (p.Arg185Ser). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 10, 2017 | The R185S variant in the ACTA1 gene has been reported previously using alternate nomenclature R183S in the heterozygous state in an individual with severe nemaline myopathy (Sparrow et al., 2003). In addition, missense variants at this same codon (R185C, R185G, R185L) have also been reported in the heterozygous state in individuals with nemaline myopathy (Laing et al., 2009), and the R185C variant, reported as R183C using alternate nomenclature, has also been reported in the somatic mosaic state in an unaffected parent of two infants affected with severe nemaline myopathy (Nowak et al., 1999). The R185S variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R185S variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, missense variants in neighboring codons (L180P, D181H, D181N, D181G, A183T, G184D, D186G) have been reported in the Human Gene Mutation Database in association with nemaline myopathy (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, we interpret R185S as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at